Incidence, severity, and etiology of drug-induced acute pancreatitis

. 2010 Oct ; 55 (10) : 2977-81. [epub] 20100525

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid20499176

INTRODUCTION: Drug-induced acute pancreatitis is considered to be a rare diagnosis. The incidence of drug-induced acute pancreatitis is usually estimated from case reports. AIM: The aim of this study was to determine the incidence, etiology, and severity of drug-induced pancreatitis during a 2-year period in a tertiary hospital. METHODS: The study was conducted as a retrospective analysis of all cases of pancreatitis in the University Hospital in Olomouc (1,432 beds) in 2006-2007. All cases of acute pancreatitis were re-evaluated and divided according to the causative factor. In drug-induced cases, the WHO Probability Scale for the evaluation of causality relationship was used. RESULTS: The inclusion criteria were met by 170 medical files. There were 91 (53%) cases in men and 79 (47%) in women, and mean age was 57 years old (5-91 years old). The etiology was in 53% biliary, 31% alcohol-induced, 12% other determined, and in 4% the cause could not be established. The proportion of drug-induced acute pancreatitis was 5.3% and it was the third most frequent cause of the AP. Azathioprine was the most frequent causative factor (three cases in two patients); all the other causative drugs were documented only in single cases: mesalazine, dexamethasone, ramipril, mycophenolate mofetil, cytarabine, and valproate. CONCLUSIONS: The diagnosis of drug-induced acute pancreatitis seems to be underestimated because of the difficulties in determining the causative agent and the need for a retrospective re-evaluation of the suspected causative factors. The disease is more probable in younger persons, women, and patients suffering from Crohn's disease.

Komentář v

PubMed

Zobrazit více v PubMed

Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 1):664-7 PubMed

Pancreas. 2003 Oct;27(3):278-9 PubMed

Am J Gastroenterol. 2006 Oct;101(10):2379-400 PubMed

Inflamm Bowel Dis. 2005 Dec;11(12):1080-4 PubMed

Aliment Pharmacol Ther. 2008 Sep 1;28(5):623-8 PubMed

Aliment Pharmacol Ther. 2004 Oct 15;20(8):843-50 PubMed

Am J Gastroenterol. 2005 May;100(5):1121-5 PubMed

Drug Saf. 2008;31(10):823-37 PubMed

Aliment Pharmacol Ther. 1996 Feb;10(1):23-38 PubMed

Gut. 1995 Oct;37(4):565-7 PubMed

Gut. 2002 Oct;51(4):536-9 PubMed

Pancreatology. 2006;6(5):464-71 PubMed

Lancet. 2000 Oct 7;356(9237):1255-9 PubMed

Clin Gastroenterol Hepatol. 2007 Jun;5(6):648-61; quiz 644 PubMed

Aliment Pharmacol Ther. 2002 Oct;16(10):1831 PubMed

J Clin Gastroenterol. 2005 Sep;39(8):709-16 PubMed

Pancreas. 2002 Apr;24(3):223-7 PubMed

Gastroenterology. 1980 Apr;78(4):813-20 PubMed

Postgrad Med J. 2004 Oct;80(948):617-8 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...